Takara Bio and Resistomap forge deal to speed up global fight against superbugs
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
Diasens and GlucoLive are designed for diabetic, Chronic Kidney Disease (CKD), and post-transplant patients who require continuous glycaemic surveillance and integrated remote care
The company says those insights can power advanced analytics and real-world evidence (RWE), helping researchers improve trial design, study feasibility, and recruitment strategies
Under the deal, Vivtex will license select oral drug-delivery technologies to Novo Nordisk
Under the deal, Quiver will receive an undisclosed advance payment and research support
Our vision is to position India not just as a consumer of advanced simulation technologies but as a creator and exporter of them
The initiative, delivered in collaboration with Accenture, integrates digitally enabled operating models powered by advanced analytics and AI across the company’s procurement, manufacturing, and distribution networks
Subscribe To Our Newsletter & Stay Updated